Verve Therapeutics (VERV)
(Delayed Data from NSDQ)
$4.80 USD
+0.01 (0.21%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $4.79 -0.01 (-0.21%) 5:48 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.70 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | 13.24% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.65 |
Next Year | -2.85 |
EPS (TTM) | -2.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.05M | 7.80M | 17.93M | 21.63M |
# of Estimates | 2 | 2 | 5 | 3 |
High Estimate | 7.00M | 8.60M | 26.39M | 28.00M |
Low Estimate | 5.10M | 7.00M | 12.39M | 12.30M |
Year ago Sales | 3.12M | 5.14M | 11.76M | 17.93M |
Year over Year Growth Est. | 93.91% | 51.75% | 52.54% | 20.63% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.70 | -0.71 | -2.65 | -2.85 |
# of Estimates | 6 | 6 | 7 | 5 |
Most Recent Consensus | -0.64 | -0.65 | -2.79 | -2.42 |
High Estimate | -0.55 | -0.57 | -2.30 | -2.42 |
Low Estimate | -0.79 | -0.86 | -2.96 | -3.35 |
Year ago EPS | -0.72 | -0.69 | -3.12 | -2.65 |
Year over Year Growth Est. | 2.78% | -2.90% | 15.06% | -7.51% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 1 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.70 | -0.71 | -2.65 | -2.85 |
7 Days Ago | -0.70 | -0.71 | -2.65 | -2.85 |
30 Days Ago | -0.70 | -0.71 | -2.65 | -2.85 |
60 Days Ago | -0.71 | -0.73 | -2.73 | -2.86 |
90 Days Ago | -0.71 | -0.73 | -2.73 | -2.86 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.70 | -0.71 | -2.65 | -2.85 |
Zacks Consensus Estimate | -0.70 | -0.71 | -2.65 | -2.85 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.59 | -0.69 | -0.72 | NA |
Estimate | -0.68 | -0.68 | -0.80 | -0.91 | NA |
Difference | 0.09 | 0.09 | 0.11 | 0.19 | 0.12 |
Surprise | 13.24% | 13.24% | 13.75% | 20.88% | 15.28% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more